All the news Showing 10 of 62 articles from: Treatment for people who use drugsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Conditional cash transfers may improve HCV screening and treatment in drug users Keith Alcorn / 22 January 2019 Conditional cash transfers – giving money to encourage use of services – may be needed to reach drug users for hepatitis C testing and treatment if they are either unaware of hepatitis ... Barriers to HCV treatment access from the drug user's point of view: stigma, complex lives and damaged veins Keith Alcorn / 16 January 2019 Despite access to hepatitis C treatment, many people who inject drugs still perceive numerous barriers to starting treatment, including the attitudes of healthcare workers, the difficulty of juggling treatment with competing demands, a ... Hepatitis C rates in US track the opioid epidemic Liz Highleyman / 14 December 2018 Nearly 2.4 million people in the United States are living with active hepatitis C virus (HCV) infection, according to the latest data from the US Centers for Disease Control and Prevention (CDC). ... People who inject drugs have a high hepatitis C cure rate despite imperfect adherence Liz Highleyman / 15 November 2018 Most people who inject drugs completed treatment with sofosbuvir/velpatasvir (Epclusa) and achieved sustained virological response (SVR) in a real-world setting, even if they had interruptions in therapy, according to a presentation at the AASLD ... What are the barriers to hepatitis C treatment in prisons? Keith Alcorn / 15 October 2018 Lack of privacy, lack of peer support and lack of harm reduction are perceived as the biggest barriers to improving the uptake of direct-acting antiviral treatment for hepatitis C among prisoners, a qualitative ... Meta-analysis shows hepatitis C treatment is highly effective for drug users Keith Alcorn / 24 September 2018 Direct-acting antiviral treatment is highly effective at curing hepatitis C in people who inject drugs and in people receiving opioid substitution therapy (OST), a systematic review and meta-analysis of 38 studies published ... People with mental health and substance use issues still less likely to receive HCV therapy Michael Carter / 24 July 2018 The proportion of people with chronic hepatitis C virus (HCV) infection who receive antiviral treatment has increased substantially since the introduction of direct-acting antivirals (DAAs), investigators from the United States report in ... Combining hepatitis C therapy and buprenorphine leads to good outcomes for people who inject drugs Liz Highleyman / 08 May 2018 Offering hepatitis C treatment and opioid substitution therapy with buprenorphine at the same location can help increase adherence and reduce harms associated with injection drug use, according to findings from the ANCHOR study ... Eight weeks of treatment with Epclusa cured almost all people with HCV receiving opioid substitution therapy Keith Alcorn / 12 April 2018 An eight-week course of sofosbuvir/velpatasvir (Epclusa) cured almost all people with hepatitis C genotype 3 without cirrhosis receiving treatment alongside opioid substitution therapy through community pharmacies or prisons in the Greater Glasgow area, ... Elimination of hepatitis C in Europe requires greater focus on prisoners and people who inject drugs Keith Alcorn / 26 February 2018 Efforts to eliminate viral hepatitis in Europe will need to focus on people who inject drugs and prisoners if European Union nations are to achieve the World Health Organization target ... ← Prev1...23456...7Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive